[Therapeutic trials of plasma exchange for idiopathic thrombocytopenic purpura, myasthenia gravis and multiple myeloma (author's transl)]. 1979

Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota

UI MeSH Term Description Entries
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D005078 Exchange Transfusion, Whole Blood Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
December 1976, Annals of internal medicine,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
April 1981, Southern medical journal,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
September 1978, Lancet (London, England),
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
April 1975, Rinsho byori. The Japanese journal of clinical pathology,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
September 1980, Zhonghua nei ke za zhi,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
April 1984, Canadian Medical Association journal,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
August 1980, Archives of internal medicine,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
October 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
January 1990, Current studies in hematology and blood transfusion,
Y Fujiwara, and K Furukawa, and Y Nakaide, and M Tanaka, and M Tanaka, and Y Hirota
March 1981, Annales de pediatrie,
Copied contents to your clipboard!